Blog Entries from November 2013

NeuroMetrix has partnered with Media Planet to raise awareness of SENSUS Pain Management through their United for Diabetes publication in USA Today

Friday, November 22nd, 2013

NeuroMetrix has partnered with Media Planet to raise awareness of SENSUS Pain Management through their United for Diabetes publication in today’s edition of USA Today (http://project.mediaplanet.com/13100.pdf)    Read More

Posted by NeuroMetrix in SENSUS Updates

Why Does SENSUS Automatically Increase the Stimulation Intensity During a Therapy Session?

Tuesday, November 19th, 2013

Nerves desensitize in response to electrical stimulation.  This process is also called “habituation” or “accommodation.”  If the stimulation intensity is not increased to offset this desensitization then the pain relief effectiveness will decrease during the course of the one hour therapy session. Read More

Posted by NeuroMetrix in SENSUS Operation

Why do SENSUS Devices Need to be Configured?

Tuesday, November 19th, 2013

The purpose of the SENSUS configuration procedure is for the device to “learn” the user’s individual stimulation requirements.  Effective pain relief with transcutaneous electrical nerve stimulation requires a stimulation intensity that is well above the sensation threshold but below the level of discomfort or pain.  Through the configuration procedure, SENSUS determines this therapeutic intensity level. Read More

Posted by NeuroMetrix in SENSUS Operation

Painful Diabetic Neuropathy Is Typically Worse in the Evening

Tuesday, November 19th, 2013

A recent study by Ian Gilron and colleagues (http://www.ncbi.nlm.nih.gov/pubmed/23370066) showed that neuropathic pain increases throughout the day leading to clinically meaningful morning-evening differences.  These results may help explain why people with painful diabetic neuropathy have difficulty falling asleep.  The authors propose that the normally low levels of endogenous opioids (i.e., the body’s natural pain modulators) in the evening may partially account for the morning-night variation in pain.  Interestingly, transcutaneous electrical nerve stimulation such as with SENSUS is known to increase endogenous opioid levels and may therefore decrease pain and improve sleep. Read More

Posted by NeuroMetrix in Painful Diabetic Neuropathy

Painful Diabetic Neuropathy May Increase the Risk of Falling

Tuesday, November 19th, 2013

A recent study by Paul Lalli and colleagues (http://www.ncbi.nlm.nih.gov/pubmed/23218484) demonstrated that people with diabetic neuropathy and neuropathic pain have more variability in their gait.  This population also reported great risk of hospitalizations for fall related injuries and a great fear of falling.  The study authors suggest that patients with painful diabetic neuropathy should be evaluated for risk of falling. Read More

Posted by NeuroMetrix in Painful Diabetic Neuropathy

Burden of Illness Associated with Painful Diabetic Neuropathy

Tuesday, November 19th, 2013

A recent study by Alesia Sadosky and colleagues (http://www.ncbi.nlm.nih.gov/pubmed/23403729) confirms what many people with painful diabetic neuropathy already know through personal experience.  The study showed that painful diabetic neuropathy is associated with high pain levels, poor sleep, anxiety, depression, and low quality of life.  Moreover health care resource utilization and costs were high in this group and increased with pain severity. Read More

Posted by NeuroMetrix in Painful Diabetic Neuropathy